AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7138736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 30648627 — intervention group
Group type: EXPERIMENTAL
Intervention: oral ibandronate (150 mg)
Number of subjects: 171
Study 30648627 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 171
Study 29846623 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging-based telemedicine intervention for IBD self-testing
Number of subjects: 193
Study 29846623 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 193
Study 26162422 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port TEP inguinal hernia repair
Number of subjects: 100
Study 26162422 — intervention group
Group type: COMPARATOR
Intervention: Conventional three-port TEP inguinal hernia repair
Number of subjects: 100
Study 24286286 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychromatic light treatment (611-650 nm or 570-850 nm, normalized to ∼ 9 J/cm²)
Number of subjects: 136
Study 24286286 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=23)
Number of subjects: 136
Study 22316322 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention (energy‐ and protein‐enriched diet, oral nutritional supplements, calcium‐vitamin D supplement, telephone counseling by a dietitian) for 3 months after discharge
Number of subjects: 210
Study 22316322 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 210
Study 22316322 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention
Number of subjects: 210
Study 20565871 — intervention group
Group type: EXPERIMENTAL
Intervention: Injurious fall types classification based on location and activity
Number of subjects: 333
Study 20565871 — intervention group
Group type: EXPERIMENTAL
Intervention: Injurious fall types
Number of subjects: 333
Study 17096462 — intervention group
Group type: EXPERIMENTAL
Intervention: MED + DBT
Number of subjects: 34
Study 17096462 — intervention group
Group type: COMPARATOR
Intervention: MED
Number of subjects: 34
Study 17096462 — intervention group
Group type: EXPERIMENTAL
Intervention: DBT + MED
Number of subjects: 34
Study 15084372 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 44
Study 15084372 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 44
Study 15084372 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study 12045414 — intervention group
Group type: EXPERIMENTAL
Intervention: Various controller medications for asthma treatment; specific medications and dosages not mentioned
Number of subjects: 0
Study 12045414 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease management and education programs; specific details not mentioned
Number of subjects: 0
Study 9793771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 9793771 — intervention group
Group type: COMPARATOR
Intervention: 0.50% timolol maleate
Number of subjects: 80
Study 9793771 — intervention group
Group type: COMPARATOR
Intervention: 1% apraclonidine
Number of subjects: 80
Study 9793771 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% apraclonidine
Number of subjects: 80
Study 8679050 — intervention group
Group type: EXPERIMENTAL
Intervention: Diapers
Number of subjects: 166
Study 8679050 — intervention group
Group type: COMPARATOR
Intervention: Underpads
Number of subjects: 166
Study 2617453 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal oxygen (2 litres/min)
Number of subjects: 7
Study 2617453 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 7
Study 848586 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide (CDX) with water
Number of subjects: 10
Study 848586 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide (CDX) with Maalox
Number of subjects: 10
Study 848586 — intervention group
Group type: COMPARATOR
Intervention: Placebo with Maalox
Number of subjects: 10
Study 848586 — intervention group
Group type: COMPARATOR
Intervention: Placebo with water
Number of subjects: 10
Study 30182319 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-metallic staining/remineralization with sodium fluoride/AS
Number of subjects: 112
Study 30182319 — intervention group
Group type: EXPERIMENTAL
Intervention: Metallic staining/remineralization with silver diamine fluoride/AS
Number of subjects: 112
Study 30182319 — intervention group
Group type: EXPERIMENTAL
Intervention: No staining/remineralization in artificial saliva (AS)
Number of subjects: 112
Study 30182319 — intervention group
Group type: COMPARATOR
Intervention: No staining/no remineralization
Number of subjects: 112
Study 28824315 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidified heated breathing circuit (HHBC)
Number of subjects: 0
Study 28824315 — intervention group
Group type: COMPARATOR
Intervention: Conventional circuit
Number of subjects: 0
Study 26636532 — intervention group
Group type: EXPERIMENTAL
Intervention: Eumastós (combination of boswellic acid, betaine, and myo-inositol)
Number of subjects: 76
Study 26636532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 24180163 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.25 mg/kg)
Number of subjects: 66
Study 24180163 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 66
Study 21627429 — intervention group
Group type: EXPERIMENTAL
Intervention: Vicryl suture
Number of subjects: 132
Study 21627429 — intervention group
Group type: COMPARATOR
Intervention: PDS suture
Number of subjects: 132
Study 19804930 — intervention group
Group type: COMPARATOR
Intervention: External jugular vein catheterisation
Number of subjects: 60
Study 19804930 — intervention group
Group type: EXPERIMENTAL
Intervention: Antecubital vein catheterisation
Number of subjects: 60
Study 16316486 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 13
Study 16316486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 15894835 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild aerobic exercise training (cycling on a leg ergometer at 80% ventilatory threshold for 30 min, 5 days/week) for 3 months
Number of subjects: 0
Study 11747848 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 113
Study 11747848 — intervention group
Group type: COMPARATOR
Intervention: Nonhemodialysis
Number of subjects: 113
Study 9296432 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflated cuff insertion technique
Number of subjects: 200
Study 9296432 — intervention group
Group type: COMPARATOR
Intervention: Standard uninflated approach
Number of subjects: 200
Study 8405011 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg capsule) after 48 h abstention
Number of subjects: 8
Study 8405011 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg capsule) after 12 h abstention
Number of subjects: 8
Study 8405011 — intervention group
Group type: COMPARATOR
Intervention: Placebo after 48 h abstention
Number of subjects: 8
Study 8405011 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg capsule)
Number of subjects: 8
Study 3950073 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg every 6 hours
Number of subjects: 10
Study 3950073 — intervention group
Group type: COMPARATOR
Intervention: Control (no cimetidine)
Number of subjects: 10
Study 30059240 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality-based cue exposure therapy (VR-CET)
Number of subjects: 64
Study 30059240 — intervention group
Group type: COMPARATOR
Intervention: Additional cognitive behavioral therapy (A-CBT)
Number of subjects: 64
Study 30405211 — intervention group
Group type: EXPERIMENTAL
Intervention: High CDA activity
Number of subjects: 124
Study 30405211 — intervention group
Group type: EXPERIMENTAL
Intervention: Low CDA activity
Number of subjects: 124
Study 26825787 — intervention group
Group type: EXPERIMENTAL
Intervention: i-Factor Bone Graft
Number of subjects: 319
Study 26825787 — intervention group
Group type: COMPARATOR
Intervention: Autograft
Number of subjects: 319
Study 24393747 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 11752
Study 24393747 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 11752
Study 24393747 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 11752
Study 23182011 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 61
Study 23182011 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham Kinesio taping
Number of subjects: 61
Study 23182011 — intervention group
Group type: COMPARATOR
Intervention: Control (no tape application)
Number of subjects: 61
Study 20031461 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral resistance training (RT: 3/week)
Number of subjects: 28
Study 20031461 — intervention group
Group type: COMPARATOR
Intervention: Electrical stimulation (ES: 1h/day)
Number of subjects: 28
Study 20031461 — intervention group
Group type: COMPARATOR
Intervention: Functional exercises (FE: 1h/day)
Number of subjects: 28
Study 18094990 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotic prophylaxis (gyrase inhibitor)
Number of subjects: 151
Study 18094990 — intervention group
Group type: COMPARATOR
Intervention: Intravenous antibiotic prophylaxis (gyrase inhibitor)
Number of subjects: 151
Study 15933555 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose HRV vaccine (10 focus-forming units)
Number of subjects: 529
Study 15933555 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose HRV vaccine (10 focus-forming units)
Number of subjects: 529
Study 15933555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 529
Study 14569951 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg, increased to 100 mg if unsatisfactory response)
Number of subjects: 60
Study 14569951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 11452854 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of rt‐PA intraoperative injection into the opened basal subarachnoid cisterns following aneurysm clipping
Number of subjects: 45
Study 11452854 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rt‐PA treatment)
Number of subjects: 45
Study 9347210 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 micrograms ethinyl estradiol (EE) for 14 days followed by 40 micrograms EE plus 125 micrograms levonorgestrel (LNG) for 12 days
Number of subjects: 21
Study 9347210 — intervention group
Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned in the abstract)
Number of subjects: 21
Study 8396707 — intervention group
Group type: EXPERIMENTAL
Intervention: NaHCO3
Number of subjects: 6
Study 8396707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 3510796 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (DMI; n = 17)
Number of subjects: 29
Study 3510796 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 29
Study 3510796 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 29
Study 29449180 — intervention group
Group type: EXPERIMENTAL
Intervention: Family therapy
Number of subjects: 832
Study 29449180 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 832
Study 27373900 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV 16/18 AS04-adjuvanted vaccine
Number of subjects: 4407
Study 27373900 — intervention group
Group type: COMPARATOR
Intervention: Aluminium hydroxide control
Number of subjects: 4407
Study 24238862 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose and maintenance dose for 6-24 hours, escalating doses: level 1 0.05 LD/MD, level 2 0.1 LD/MD, level 3 0.2 LD/MD)
Number of subjects: 42
Study 24238862 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 42
Study 22420876 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Toothbrush System (DTS)
Number of subjects: 21
Study 22420876 — intervention group
Group type: COMPARATOR
Intervention: Control Group (COG)
Number of subjects: 21
Study 19453623 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole treatment (3 and 6 months)
Number of subjects: 8
Study 19453623 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole treatment (6 months)
Number of subjects: 8
Study 17394095 — intervention group
Group type: EXPERIMENTAL
Intervention: Stented group (60 patients)
Number of subjects: 120
Study 17394095 — intervention group
Group type: COMPARATOR
Intervention: Unstented group (60 patients)
Number of subjects: 120
Study 16620253 — intervention group
Group type: EXPERIMENTAL
Intervention: Nipple shields
Number of subjects: 32
Study 12514591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) with foot compression at 80 mm Hg
Number of subjects: 12
Study 12514591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) with calf compression at 40 mm Hg
Number of subjects: 12
Study 12514591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) with calf + thigh compression
Number of subjects: 12
Study 12514591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) in the 15-degree head-down position
Number of subjects: 12
Study 12514591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) in horizontal and 15-degree head-up positions
Number of subjects: 12
Study 12514591 — intervention group
Group type: COMPARATOR
Intervention: Simple elevation of the legs
Number of subjects: 12
Study 10994312 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared kangaroo care (holding all three infants at once)
Number of subjects: 1
Study 10994312 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-bedding the triplets in a single pediatric crib
Number of subjects: 1
Study 8803897 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine diphosphate (CDP) 250 mg/day
Number of subjects: 24
Study 8803897 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 24
Study 31325122 — intervention group
Group type: EXPERIMENTAL
Intervention: Active photobiomodulation (super‐pulsed laser 905 nm, red 640 nm, infrared 875 nm)
Number of subjects: 30
Study 31325122 — intervention group
Group type: COMPARATOR
Intervention: Sham photobiomodulation
Number of subjects: 30
Study 30041682 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus aurantium + Caffeine (CA + C) (100 mg of CA and 100 mg of C)
Number of subjects: 10
Study 30041682 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 10
Study 26952348 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 0
Study 26952348 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 0
Study 26952348 — intervention group
Group type: COMPARATOR
Intervention: Current standard of care
Number of subjects: 0
Study 23932743 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacologic pain management education with distraction (experimental group)
Number of subjects: 93
Study 23932743 — intervention group
Group type: COMPARATOR
Intervention: Pharmacologic pain management education (control group)
Number of subjects: 93
Study 23769603 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 240
Study 23769603 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional surgery (CS)
Number of subjects: 240
Study 23769603 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foam sclerotherapy (UGFS)
Number of subjects: 240
Study 23769603 — intervention group
Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 240
Study 20492042 — intervention group
Group type: EXPERIMENTAL
Intervention: Music listening group
Number of subjects: 137
Study 20492042 — intervention group
Group type: EXPERIMENTAL
Intervention: Headphone group
Number of subjects: 137
Study 20492042 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 137
Study 18625626 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K supplementation (phylloquinone)
Number of subjects: 378
Study 18625626 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K supplementation (phylloquinone) in participants with insufficient vitamin K at baseline
Number of subjects: 378
Study 18625626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study 15715187 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (30mg per day for 7 days)
Number of subjects: 29
Study 15715187 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (800 microg twice daily for 4 weeks)
Number of subjects: 29
Study 15715187 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 29
Study 15715187 — intervention group
Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 29
Study 11966502 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 tablets (42 g) of sodium phosphate
Number of subjects: 100
Study 11966502 — intervention group
Group type: EXPERIMENTAL
Intervention: 32 tablets (48 g) of sodium phosphate
Number of subjects: 100
Study 9930706 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization (TMR)
Number of subjects: 198
Study 9930706 — intervention group
Group type: COMPARATOR
Intervention: Continued medical management
Number of subjects: 198
Study 7503931 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrigley's Spearmint chewing-gum
Number of subjects: 12
Study 7503931 — intervention group
Group type: COMPARATOR
Intervention: gum-base
Number of subjects: 12
Study 2405462 — intervention group
Group type: EXPERIMENTAL
Intervention: Betadine solution standardized
Number of subjects: 0
Study 2405462 — intervention group
Group type: COMPARATOR
Intervention: Merfen tincture
Number of subjects: 0
Study 7000234 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nylon sutures
Number of subjects: 105
Study 7000234 — intervention group
Group type: COMPARATOR
Intervention: Interrupted nylon sutures
Number of subjects: 105
Study 31826369 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5% oral carbohydrate drink
Number of subjects: 70
Study 31826369 — intervention group
Group type: COMPARATOR
Intervention: Pure water (control)
Number of subjects: 70
Study 25952614 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic adrenalectomy (LA)
Number of subjects: 51
Study 25952614 — intervention group
Group type: COMPARATOR
Intervention: Open adrenalectomy
Number of subjects: 51
Study 23786487 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stockings made with thread reflecting long-wave infrared (LWIR) radiation
Number of subjects: 30
Study 23786487 — intervention group
Group type: COMPARATOR
Intervention: Compression stockings without thread reflecting long-wave infrared (LWIR) radiation
Number of subjects: 30
Study 21411615 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice (double-strength, 54% juice, 835 mg total polyphenols, 94 mg anthocyanins, 480 mL/d for 4 weeks)
Number of subjects: 44
Study 21411615 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage (480 mL/d for 4 weeks)
Number of subjects: 44
Study 21411615 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice (single 480-mL portion)
Number of subjects: 44
Study 19451330 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone‐incorporated intrauterine system (IUS; Mirena)
Number of subjects: 172
Study 19451330 — intervention group
Group type: COMPARATOR
Intervention: Copper intrauterine contraceptive device (IUCD)
Number of subjects: 172
Study 19451330 — intervention group
Group type: COMPARATOR
Intervention: Copper IUCD
Number of subjects: 172
Study 16617567 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 142
Study 16617567 — intervention group
Group type: COMPARATOR
Intervention: Dose-intensified chemotherapy
Number of subjects: 142
Study 15598474 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 141
Study 15598474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 11392270 — intervention group
Group type: EXPERIMENTAL
Intervention: Drifting sinusoidal grating background stimulation during computer game training for 10 days (2 sessions of 20 minutes daily)
Number of subjects: 14
Study 11392270 — intervention group
Group type: COMPARATOR
Intervention: Placebo group with neutral background during computer game training for 10 days (2 sessions of 20 minutes daily)
Number of subjects: 14
Study 9271751 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of blood conservation strategies; specific interventions not detailed.
Number of subjects: 0
Study 8303896 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse counseling message
Number of subjects: 57
Study 8303896 — intervention group
Group type: COMPARATOR
Intervention: Videotape or booklet on smoking cessation
Number of subjects: 57
Study 8303896 — intervention group
Group type: COMPARATOR
Intervention: Usual care at the clinic
Number of subjects: 57
Study 3661275 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipeline methodology with confidentiality but not anonymity
Number of subjects: 0
Study 3661275 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipeline methodology with anonymity assured
Number of subjects: 0
Study 3661275 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group) for alcohol disclosure
Number of subjects: 0
Study 29650060 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment gastrostomy tube feeding
Number of subjects: 75
Study 29650060 — intervention group
Group type: COMPARATOR
Intervention: Oral feeding plus as-required nasogastric tube feeding
Number of subjects: 75
Study 28448457 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (2800 IU daily for eight weeks)
Number of subjects: 197
Study 25651444 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI at midlife
Number of subjects: 2817
Study 25651444 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger WC at midlife
Number of subjects: 2817
Study 25651444 — intervention group
Group type: COMPARATOR
Intervention: Obese participants in midlife
Number of subjects: 2817
Study 25651444 — intervention group
Group type: EXPERIMENTAL
Intervention: Midlife dietary patterns adjustment
Number of subjects: 2817
Study 25651444 — intervention group
Group type: EXPERIMENTAL
Intervention: No relationships observed
Number of subjects: 2817